Financial Post
TORONTO, May 26, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is pleased to announce a $85,000 research grant awarded to Dr. Stéphane Angers at the University of Toronto for his project, “Discovery of Druggable Vulnerabilities in Hypermutant Recurrent Glioblastoma.” This innovative research initiative aims to identify new therapeutic strategies for glioblastoma (GBM…
Read More
Brain Cancer Canada Awards $85K to Cutting-Edge Recurrent Glioblastoma Research
GlobeNewswire
16:26
TORONTO, May 26, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is pleased to announce a $85,000 research grant awarded to Dr. Stéphane Angers at the University of Toronto for his project, “Discovery of Druggable Vulnerabilities in Hypermutant Recurrent Glioblastoma.” This innovative research initiative aims to identify new therapeutic strategies for glioblastoma (GBM…
